Pharma Archives - Page 66 of 76 - Life Sciences Times

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

August 11, 2025

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

August 7, 2025

THIS WEEK'S STORIES

FDA Clears Thermo Fisher Test to Match Lung Cancer Patients With Newly Approved HER2-Targeted Drug

August 11, 2025

FDA Grants De Novo Authorization to ArteraAI Prostate, First AI-Powered Digital Pathology Tool for Prostate Cancer Prognosis

August 13, 2025

Palleon Pharmaceuticals Doses First Patient in Phase 2 Trial of E-602 for Autoimmune Kidney Disease

August 7, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Sarepta Therapeutics Advances siRNA Program for DM1, Sells Arrowhead Stake to Fund $100M Milestone Payment

Survey Finds Pediatricians Prefer Genexa’s Ingredient Profiles Over Children’s Tylenol® Products

Innoviva Specialty Therapeutics Earns Dual Nominations for 2025 Prix Galien USA Best Pharmaceutical Product Award

Merck’s KEYTRUDA-Padcev Combo Improves Survival for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients in Phase 3 Trial

Akamis Bio Appoints C4 Therapeutics CEO Andrew Hirsch to Board of Directors

Most Read

VitaTek Adds In-House Balloon Development Manufacturing to Streamline Medical Device Production

Apreo Health Treats First Patient in Pivotal BREATHE-3 Trial for Severe Emphysema

Archimedic Names Aaron Pavkov Chief Innovation Officer to Drive Medical Device Development